CMG Global Holdings’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$470K Sell
1,869
-10
-0.5% -$2.15K 0.2% 63
2026
Q1
$409K Sell
1,879
-33
-2% -$7.32K 0.19% 65
2025
Q4
$415K Sell
1,912
-10
-0.5% -$2.28K 0.18% 66
2025
Q3
$435K Sell
1,922
-155
-7% -$31.6K 0.21% 65
2025
Q2
$392K Sell
2,077
-1,683
-45% -$313K 0.21% 64
2025
Q1
$678K Sell
3,760
-136
-3% -$26.4K 0.44% 48
2024
Q4
$659K Buy
3,896
+61
+2% +$11.2K 0.36% 54
2024
Q3
$757K Hold
3,835
0.43% 49
2024
Q2
$658K Hold
3,835
0.44% 50
2024
Q1
$698K Hold
3,835
0.48% 46
2023
Q4
$677K Hold
3,835
0.49% 48
2023
Q3
$572K Hold
3,835
0.49% 47
2023
Q2
$517K Hold
3,835
0.42% 53
2023
Q1
$611K Hold
3,835
0.55% 44
2022
Q4
$620K Hold
3,835
0.59% 43
2022
Q3
$515K Buy
3,835
+200
+6% +$28.7K 0.56% 45
2022
Q2
$557K Hold
3,635
0.58% 45
2022
Q1
$589K Hold
3,635
0.48% 49
2021
Q4
$492K Buy
3,635
+100
+3% +$11.8K 0.32% 60
2021
Q3
$381K Buy
3,535
+443
+14% +$50.6K 0.28% 61
2021
Q2
$348K Buy
3,092
+100
+3% +$11.3K 0.26% 64
2021
Q1
$324K Buy
+2,992
New +$320K 0.28% 63

Other funds holding ABBV

CMG Global Holdings's ABBV Position: Q2 2026 in Review

CMG Global Holdings reduced its AbbVie (ABBV) stake by 0.53% in Q2 2026, selling an estimated $2.15K and leaving 1,869 shares worth $470K. The position accounts for 0.2% of the portfolio, ranked #63.

CMG Global Holdings first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. The position peaked at $757K in Q3 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • CMG Global Holdings held 1,869 shares of AbbVie worth $470K as of Q2 2026.
  • CMG Global Holdings sold 10 AbbVie shares in Q2 2026, an estimated $2.15K.
  • AbbVie made up 0.2% of CMG Global Holdings's portfolio in Q2 2026, its #63 holding.
  • CMG Global Holdings first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • CMG Global Holdings's AbbVie position peaked at $757K in Q3 2024.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CMG Global Holdings's 13F filing for Q2 2026, filed 28 Jul 2026.